Bayesian decision theoretic two-stage design in Phase II clinical trials with survival endpoint

Por Zhao, Lili, Taylor, Jeremy M.G., Schuetze, Scott M
Publicado em 2012

Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy

Por Zyczynski, Laura E., McHugh, Jonathan B., Gribbin, Thomas E., Schuetze, Scott M.
Publicado no Case Rep Oncol Med (2015)

[F-18]-fluorodeoxy-D-glucose Positron Emission Tomography Response is Associated with Outcome for Extremity Osteosarcoma in Children and Young Adults

Por Hawkins, Douglas S., Conrad, Ernest U., Butrynski, James E., Schuetze, Scott M., Eary, Janet F.
Publicado em 2009

The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004)

Por Beebe-Dimmer, Jennifer L, Cetin, Karynsa, Fryzek, Jon P, Schuetze, Scott M, Schwartz, Kendra
Publicado em 2009

Sarcoma Mid-Therapy [F-18]Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Patient Outcome

Por Eary, Janet F., Conrad, Ernest U., O’Sullivan, Janet, Hawkins, Douglas S., Schuetze, Scott M., O’Sullivan, Finbarr
Publicado em 2014

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

Por Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Publicado no BMC Cancer (2016)

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival

Por Koshkin, Vadim S., Bolejack, Vanessa, Schwartz, Lawrence H., Wahl, Richard L., Chugh, Rashmi, Reinke, Denise K., Zhao, Binsheng, O, Joo H., Patel, Shreyaskumar R., Schuetze, Scott M., Baker, Laurence H.
Publicado no J Clin Oncol (2016)

Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

Por Rutkowski, Piotr, Van Glabbeke, Martine, Rankin, Cathryn J., Ruka, Wlodzimierz, Rubin, Brian P., Debiec-Rychter, Maria, Lazar, Alexander, Gelderblom, Hans, Sciot, Raf, Lopez-Terrada, Dolores, Hohenberger, Peter, van Oosterom, Allan T., Schuetze, Scott M.
Publicado em 2010

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing’s sarcoma: a phase 1 expansion cohort stu...

Por Olmos, David, Postel-Vinay, Sophie, Molife, L Rhoda, Okuno, Scott H, Schuetze, Scott M, Paccagnella, M Luisa, Batzel, Gretchen N, Yin, Donghua, Pritchard-Jones, Kathryn, Judson, Ian, Worden, Francis P, Gualberto, Antonio, Scurr, Michelle, de Bono, Johann S, Haluska, Paul
Publicado em 2009

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Al...

Por Pappo, Alberto S., Patel, Shreyaskumar R., Crowley, John, Reinke, Denise K., Kuenkele, Klaus-Peter, Chawla, Sant P., Toner, Guy C., Maki, Robert G., Meyers, Paul A., Chugh, Rashmi, Ganjoo, Kristen N., Schuetze, Scott M., Juergens, Heribert, Leahy, Michael G., Geoerger, Birgit, Benjamin, Robert S., Helman, Lee J., Baker, Laurence H.
Publicado em 2011

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multice...

Por Demetri, George D., von Mehren, Margaret, Jones, Robin L., Hensley, Martee L., Schuetze, Scott M., Staddon, Arthur, Milhem, Mohammed, Elias, Anthony, Ganjoo, Kristen, Tawbi, Hussein, Van Tine, Brian A., Spira, Alexander, Dean, Andrew, Khokhar, Nushmia Z., Park, Youn Choi, Knoblauch, Roland E., Parekh, Trilok V., Maki, Robert G., Patel, Shreyaskumar R.
Publicado no J Clin Oncol (2016)

Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing

Por Robinson, Dan R., Wu, Yi-Mi, Kalyana-Sundaram, Shanker, Cao, Xuhong, Lonigro, Robert J., Sung, Yun-Shao, Chen, Chun-Liang, Zhang, Lei, Wang, Rui, Su, Fengyun, Iyer, Matthew K., Roychowdhury, Sameek, Siddiqui, Javed, Pienta, Kenneth J., Kunju, Lakshmi P., Talpaz, Moshe, Mosquera, Juan Miguel, Singer, Samuel, Schuetze, Scott M., Antonescu, Cristina R., Chinnaiyan, Arul M.
Publicado em 2013

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

Por Maki, Robert G., D'Adamo, David R., Keohan, Mary L., Saulle, Michael, Schuetze, Scott M., Undevia, Samir D., Livingston, Michael B., Cooney, Matthew M., Hensley, Martee L., Mita, Monica M., Takimoto, Chris H., Kraft, Andrew S., Elias, Anthony D., Brockstein, Bruce, Blachère, Nathalie E., Edgar, Mark A., Schwartz, Lawrence H., Qin, Li-Xuan, Antonescu, Cristina R., Schwartz, Gary K.
Publicado em 2009

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

Por Schwartz, Gary K, Tap, William D, Qin, Li-Xuan, Livingston, Michael B, Undevia, Samir D, Chmielowski, Bartosz, Agulnik, Mark, Schuetze, Scott M, Reed, Damon R, Okuno, Scott H, Ludwig, Joseph A, Keedy, Vicki, Rietschel, Petra, Kraft, Andrew S, Adkins, Douglas, Van Tine, Brian A, Brockstein, Bruce, Yim, Vincent, Bitas, Christiana, Abdullah, Abdul, Antonescu, Cristina R, Condy, Mercedes, Dickson, Mark A, Vasudeva, Shyamprasad Deraje, Ho, Alan L, Doyle, L Austin, Chen, Helen X, Maki, Robert G
Publicado em 2013